- Zhang, et al. SARs of a novel series of s-triazine compounds targeting vimentin to induce methuotic phenotype. Eur J Med Chem. 2021 Mar 15;214:113188. doi: 10.1016/j.ejmech.2021.113188.
- Wu, et al: A Small Vimentin-Binding Molecule Blocks Cancer Exosome Release and Reduces Cancer Cell Mobility. Frontiers in Pharmacol. 12:1597, 2021. doi: 10.3389/fphar.2021.627394.
- Li, et al. A vimentin-targeting oral compound with host-directed antiviral and anti-inflammatory actions addresses multiple features of COVID-19 and related diseases. bioRxiv. doi: 10.1101/2021.08.26.457884.
This document was printed from http://www.aludapharm.com/science/publications.html